{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Ph1 T-cell lymphoma study: An open-label, multi-center, non-randomized phase I dose escalation study to investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 given as monotherapy in patients with relapsed or refractory T-cell Lymphoma","item":"https:\/\/www.regionalcancercare.org\/trials\/ph1-t-cell-lymphoma-study-an-open-label-multi-center-non-randomized-phase-i-dose-escalation-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-ono-4685-giv\/#breadcrumbitem"}]}